Unit dosing of darbepoetin alfa for thetreatment of anemia in patients with end-stage renal disease being switched from recombinant human erythropoietin: Results of a phase IIIb, 27-week, multicenter, open-label study in Greek patients

✍ Scribed by Georgios Bristoyiannis; Nikolaos Germanos; Dimitrios Grekas; Christos Hatzidimitriou; Christos Iatrou; Dimitrios Memmos; Spiros Moutafis; Konstantinos Papachristoforou; Antonis Papadoniou; Michalis Pappas; George A. Sakellariou; Kostas C. Siamopoulos; Konstantinos Sombolos; Kiriaki Stamatelou; Charalambos P. Stathakis; Georgios Stavgiannoudakis; Spiros Stratigis; Christos Syrganis; Dimitris Tsakiris; Dimitris Valis; Jannis G. Vlahojannis; Dimosthenis Vlassopoulos

• Book ID: 116396222
• Publisher: Elsevier Science
• Year: 2005
• Tongue: English
• Weight: 930 KB
• Volume: 66
• Category: Article
• ISSN: 0011-393X
• DOI: 10.1016/j.curtheres.2005.06.009